Keyphrases
Treatment Refractory
100%
Chordoma
100%
Clinical Trials
20%
Treatment Options
6%
Transforming Growth Factor-β
6%
Radiotherapy
6%
Tyrosine Kinase Inhibitor
6%
Programmed Death-ligand 1 (PD-L1)
6%
Standard of Care
6%
Microenvironment
6%
Pazopanib
6%
Viral Vectors
6%
Immune Checkpoint Inhibitors
6%
Vaccine Types
6%
Recurrence Rate
6%
Systemic Treatment
6%
Ventromedial
6%
Human Tumor Cells
6%
PubMed
6%
Notochord
6%
Clinical Trial Design
6%
Aggressive Tumor
6%
Further Treatment
6%
Promising Areas
6%
All Clinical Trials
6%
Brachyury
6%
Patient Accrual
6%
Skull Base
6%
Mobile Spine
6%
Medicine and Dentistry
Chordoma
100%
Immunotherapy
100%
Clinical Trial
26%
Sacrum
13%
Neoplasm
6%
Programmed Death-Ligand 1
6%
Systemic Therapy
6%
Immune Checkpoint Inhibitor
6%
Recurrence Risk
6%
Clinical Trial Design
6%
Virus Vector
6%
Tyrosine-Kinase Inhibitor
6%
Autologous Tumor Cell
6%
Skull Base
6%
Pazopanib
6%
Notochord
6%
Transforming Growth Factor Beta
6%
Radiation Therapy
6%
Pharmacology, Toxicology and Pharmaceutical Science